Table 4.

Infection rates for opportunistic and serious infection patients treated with Cyclophosphamide

Type of infection	Number of Infection	Incidence rate (per100) person-Year	(95% CL) Per100 person-year
Opportunistic Infections	12	39.648	(22.03 – 71.39)
PJP	1	1.290	(0.037 – 44.280)
Mucosal candidiasis	2	4.624	(0.875 – 24.420)
Fungal skin infection	1	0.000	(0.000 – 0.000)
Shingles	5	9.107	(2.292 – 36.192)
Mucocutaneous HSV-1 infection	3	7.477	(1.945 – 28.752)
Serious Infections	5	12.948	(4.42 – 39.94)
Line sepsis	2	0.797	(0.009 – 73.224)
UTI	2	4.279	(0.694 – 28.388)
Serious PJP Infection	1	1.290	(0.037 – 44.280)

Incidence rates are the number of events per 100 person-years.

The age and ANC adjusted Poisson-regression model were used to analyze the incidence rate and their 95% confidence intervals (95% Cls).

^**Total 42 courses of cyclophosphamide in 31 patients; denominator used is 42.